EMEA-001078-PIP01-10

Key facts

Active substance
Lixivaptan
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/257/2011
PIP number
EMEA-001078-PIP01-10
Pharmaceutical form(s)
Capsule, hard
Condition(s) / indication(s)
Treatment of hyponatraemia
Route(s) of administration
Oral use
Contact for public enquiries
Cardiokine Biopharma, LLC 
USA
struocchio@cardiokine.com
+1 2153991219
+1 2153991230
Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating